Zoetis (ZTS) Shares Outstanding (Weighted Average) (2012 - 2026)

Zoetis (ZTS) reported Shares Outstanding (Weighted Average) of $422.1 million for Q1 2026, down 5.7% year-over-year from $447.6 million in Q1 2025, and down 4.81% quarter-over-quarter from $443.4 million in Q4 2025.

Zoetis (ZTS) Shares Outstanding (Weighted Average) (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $422.1 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $422.1 million, down 5.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $422.1 million (down 5.7% YoY), and the FY2025 annual result was $443.4 million, down 2.37% from the prior year.
  • Shares Outstanding (Weighted Average) fell to $422.1 million in Q1 2026 per ZTS's latest filing, from $443.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $472.2 million in Q1 2022 and troughed at $422.1 million in Q1 2026.
  • A 5-year average of $456.4 million and a median of $458.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) retreated 0.69% in 2022, then slipped 5.7% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $468.9 million in 2022, then retreated by 1.65% to $461.2 million in 2023, then fell by 1.51% to $454.2 million in 2024, then decreased by 2.37% to $443.4 million in 2025, then fell by 4.81% to $422.1 million in 2026.
  • Business Quant data shows ZTS's Shares Outstanding (Weighted Average) at $422.1 million in Q1 2026, $443.4 million in Q4 2025, and $445.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 88.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 422.10 Mn
Dec 31, 2025 443.44 Mn
Sep 30, 2025 445.20 Mn
Jun 30, 2025 446.30 Mn
Mar 31, 2025 447.60 Mn
Dec 31, 2024 454.20 Mn
Sep 30, 2024 455.40 Mn
Jun 30, 2024 456.70 Mn
Mar 31, 2024 458.00 Mn
Dec 31, 2023 461.17 Mn
Sep 30, 2023 460.30 Mn
Jun 30, 2023 462.70 Mn
Mar 31, 2023 463.50 Mn
Dec 31, 2022 468.89 Mn
Sep 30, 2022 470.00 Mn
Jun 30, 2022 471.10 Mn
Mar 31, 2022 472.20 Mn
Dec 31, 2021 474.35 Mn
Sep 30, 2021 474.00 Mn
Jun 30, 2021 474.80 Mn